How Danaher's Expanded Infectious Disease Partnership Could Shape DHR's Recurring Revenue Story [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
molecular workflows for identifying bacterial and fungal pathogens, antimicrobial resistance, and genomic antibiotic susceptibility in bloodstream infection and sepsis research. This move deepens Danaher's involvement in complex infectious disease diagnostics, potentially reinforcing its position in high-value, research-oriented testing as healthcare systems seek more precise tools. We'll now explore how this expanded infectious disease diagnostics partnership could influence Danaher's existing investment narrative around recurring revenues and innovation. Uncover the next big thing with 25 elite penny stocks that balance risk and reward. Danaher Investment Narrative Recap To own Danaher, you generally need to believe in its ability to grow recurring, consumable-heavy revenues across diagnostics, life sciences, and biotechnology while managing cost pressures and mixed end-market demand. The expanded Cepheid and Oxford Nanopore partnership strengthens Danaher's presence in co
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Barclays and Evercore Stay Positive on Danaher (DHR) Despite Cutting Price Targets [Yahoo! Finance]Yahoo! Finance
- Danaher (DHR) was given a new $249.00 price target by Robert W. Baird.MarketBeat
- Danaher (DHR) was given a new $205.00 price target by Rothschild & Co Redburn.MarketBeat
- Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration [Yahoo! Finance]Yahoo! Finance
- Danaher (DHR) had its price target lowered by TD Cowen from $270.00 to $245.00. They now have a "buy" rating on the stock.MarketBeat
DHR
Earnings
- 1/28/26 - Beat
DHR
Sec Filings
- 4/17/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/25/26 - Form ARS
- DHR's page on the SEC website